Experiences with
Lymphomas800 public posts
Want to take advantage of all our features? Just log in!
or
Review article summarises management strategies for those with CLL harbouring complex karyotype
On 6 January 2025, the journal [i]BJ Haem[/i] published a review article titled [i]Management strategies for patients with chronic lymphocytic leukaemia harbouring complex karyotype[/i] written by a team from Padua, Italy. The article summary explains its aims:
[i]"Chronic lymphocytic leukaemia
Wednesday's Word
[u][i]Golexanolone[/i][/u]
[i]A relatively new drug that is in clinical trial mostly being tested to help relieve cognitive and motor functions. It is hopefully to be used for Parkinson patients as well as those with hepatic encephalopathy in PBC. it was being tested in the laboratories
Does cognitive decline accelerate in older adults after diagnosis with CLL compared with the cognitive trajectory seen in normal aging?
decreased physical activity, and cardiovascular risk, which may impact cognition.14-16 Second, since HMNs are systemic diseases affecting the immune and hematopoietic systems, their disease biology may influence cognition independent of treatment, as has been suggested in chronic lymphocytic leukemia and lymphomas